87 related articles for article (PubMed ID: 26255344)
1. METALLOPROTEINS DURING DEVELOPMENT OF WALKER-256 CARCINOSARCOMA RESISTANT PHENOTYPE.
Chekhun VF; Lozovska YV; Burlaka AP; Ganusevich II; Shvets YV; Lukianova NY; Todor IM; Demash DV; Pavlova AA; Naleskina LA
Ukr Biochem J; 2015; 87(2):103-12. PubMed ID: 26255344
[TBL] [Abstract][Full Text] [Related]
2. Remodulating effect of doxorubicin on the state of iron-containing proteins, and redox characteristics of tumor with allowance for its sensitivity to cytostatic agents.
Chekhun VF; Lozovska YV; Burlaka AP; Ganusevich LI; Shvets YV; Lukyanova NY; Todor IM; Tregubova NA; Naleskina LA
Ukr Biochem J; 2016; 88(1):99-108. PubMed ID: 29227592
[TBL] [Abstract][Full Text] [Related]
3. Redox-regulation of gelatinases during growth of cisplatin-sensitive and resistant Guerin carcinoma.
Burlaka AP; Ganusevich II; Lozovska YV; Lukyanova NY; Chekhun VF
Exp Oncol; 2015 Mar; 37(1):36-9. PubMed ID: 25804229
[TBL] [Abstract][Full Text] [Related]
4. Structural changes of serum albumin in response to oxidative stress caused by Walker-256 carcinosarcoma growth.
Sarnatskaya VV; Yushko LA; Prokopenko IV; Hudenko NV; Maslenny VN; Paziuk LM; Bubnovskaya LN; Nikolaev VG
Exp Oncol; 2020 Mar; 42(1):40-45. PubMed ID: 32231185
[TBL] [Abstract][Full Text] [Related]
5. Metabolic changes during development of Walker-256 carcinosarcoma resistance to doxorubicin.
Todor IN; Lukyanova NY; Shvets YV; Lozovska YV; Chekhun VF
Exp Oncol; 2015 Mar; 37(1):19-22. PubMed ID: 25804226
[TBL] [Abstract][Full Text] [Related]
6. Morphological features of doxorubicin-resistant Walker 256 carcinosarcoma and response of mast cells.
Boroday NV; Chekhun VF
Exp Oncol; 2018 Mar; 40(1):42-47. PubMed ID: 29600974
[TBL] [Abstract][Full Text] [Related]
7. Structure and expression of genes involved in transport and storage of iron in red-blooded and hemoglobin-less antarctic notothenioids.
Scudiero R; Trinchella F; Riggio M; Parisi E
Gene; 2007 Aug; 397(1-2):1-11. PubMed ID: 17570620
[TBL] [Abstract][Full Text] [Related]
8. Dysfunction of the retinal pigment epithelium with age: increased iron decreases phagocytosis and lysosomal activity.
Chen H; Lukas TJ; Du N; Suyeoka G; Neufeld AH
Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1895-902. PubMed ID: 19151392
[TBL] [Abstract][Full Text] [Related]
9. Melatonin controls oxidative stress and modulates iron, ferritin, and transferrin levels in adriamycin treated rats.
Othman AI; El-Missiry MA; Amer MA; Arafa M
Life Sci; 2008 Oct; 83(15-16):563-8. PubMed ID: 18793653
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of iron-regulating genes in monkey and human glaucoma.
Farkas RH; Chowers I; Hackam AS; Kageyama M; Nickells RW; Otteson DC; Duh EJ; Wang C; Valenta DF; Gunatilaka TL; Pease ME; Quigley HA; Zack DJ
Invest Ophthalmol Vis Sci; 2004 May; 45(5):1410-7. PubMed ID: 15111596
[TBL] [Abstract][Full Text] [Related]
11. The dynamics of reactive oxygen species in photodynamic therapy with tetra sulfophenyl-porphyrin.
Clichici S; Filip A; Daicoviciu D; Ion RM; Mocan T; Tatomir C; Rogojan L; Olteanu D; Muresan A
Acta Physiol Hung; 2010 Mar; 97(1):41-51. PubMed ID: 20233689
[TBL] [Abstract][Full Text] [Related]
12. Alteration in iron metabolism during retinal degeneration in rd10 mouse.
Deleon E; Lederman M; Berenstein E; Meir T; Chevion M; Chowers I
Invest Ophthalmol Vis Sci; 2009 Mar; 50(3):1360-5. PubMed ID: 18997094
[TBL] [Abstract][Full Text] [Related]
13. Regulation of iron metabolism-related genes in diethylnitrosamine-induced mouse liver tumors.
Youn P; Kim S; Ahn JH; Kim Y; Park JD; Ryu DY
Toxicol Lett; 2009 Feb; 184(3):151-8. PubMed ID: 19061943
[TBL] [Abstract][Full Text] [Related]
14. Iron metabolism disturbances in the MCF-7 human breast cancer cells with acquired resistance to doxorubicin and cisplatin.
Chekhun VF; Lukyanova NY; Burlaka CA; Bezdenezhnykh NA; Shpyleva SI; Tryndyak VP; Beland FA; Pogribny IP
Int J Oncol; 2013 Nov; 43(5):1481-6. PubMed ID: 23969999
[TBL] [Abstract][Full Text] [Related]
15. Regression of Walker 256 carcinosarcoma in vasopressin-deficient Brattleboro rats is accompanied by a changed laminin pattern.
Khegay II; Ivanova LN
Biochem Genet; 2015 Apr; 53(1-3):1-7. PubMed ID: 25854851
[TBL] [Abstract][Full Text] [Related]
16. Role of ferritin alterations in human breast cancer cells.
Shpyleva SI; Tryndyak VP; Kovalchuk O; Starlard-Davenport A; Chekhun VF; Beland FA; Pogribny IP
Breast Cancer Res Treat; 2011 Feb; 126(1):63-71. PubMed ID: 20390345
[TBL] [Abstract][Full Text] [Related]
17. [Changes in the free-radical state and level of free iron during the formation of drug resistance in tumor cells].
Saprin AN; Kalinina EV; Serezhenkov VA; Kotova IaN; Solomka VS; Shcherbak NP
Biofizika; 2006; 51(3):485-90. PubMed ID: 16808348
[TBL] [Abstract][Full Text] [Related]
18. (-)-Epigallocatechin-3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifen-resistant cells.
Farabegoli F; Papi A; Orlandi M
Biosci Rep; 2011 Apr; 31(2):99-108. PubMed ID: 20446926
[TBL] [Abstract][Full Text] [Related]
19. The influence of lactoferrin on elemental homeostasis and activity of metal-containing enzymes in rats with Walker-256 carcinosarcoma.
Lozovska YV; Andrusishina IM; Lukianova NY; Burlaka AP; Naleskina LA; Todor IN; Chekhun VF
Exp Oncol; 2019 Mar; 41(1):20-25. PubMed ID: 30932415
[TBL] [Abstract][Full Text] [Related]
20. Artesunate induces ROS-mediated apoptosis in doxorubicin-resistant T leukemia cells.
Efferth T; Giaisi M; Merling A; Krammer PH; Li-Weber M
PLoS One; 2007 Aug; 2(8):e693. PubMed ID: 17668070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
